- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
Complaint alleged Symbicort cost-calculator webpage lacked prescribing information and generic name and breached a prior undertaking. Panel and Appeal Board found the…
Lilly’s ‘Barber’s Box’ slide deck comparing GLP‑1RAs was ruled misleading: shaded comparative boxes and selective CVOT subgroup messaging implied advantages without adequate…
PMCPA found AstraZeneca’s Symbicort dosing web copy misleading due to omitted max dose/SPC warning (Clause 2 censure). Separate breaches on Trixeo site…
Four Eliquis (apixaban) patient booklets on a company website weren’t updated after SPC changes. Panel found misleading omissions/inaccuracies (Clause 6.1) and failure…
Panel said Daiichi Sankyo’s patient-organisation “cholesterol test” campaign was a contract for services, making the company responsible for materials. Some public educational…
A post-prescription patient website for Nilemdo/Nustendi was ruled to promote Nustendi to patients prescribed Nilemdo by highlighting ezetimibe’s mechanism of action, likely…
PMCPA found Galapagos’ Jyseleca website homepage banner ‘Strength of balance’ was ambiguous and insufficiently explained, breaching Clause 6.1. ‘Delivering breakthroughs…’ drew concern…
At ESC-HFA 2022, Ferinject banner ads ran on the congress site/Medscape and unintentionally reached UK HCPs for 60 days without certification by…
Eight UK-based AstraZeneca employees ‘liked’ a US LinkedIn post linking to an Enhertu press release. The PMCPA ruled this proactively disseminated promotional…
Complaint about Trixeo promotional claims (spacer use, lung deposition %, and missing Symbicort PI). PMCPA Panel found no breach of the 2021…
At ERS 2022, GSK-sponsored symposium slides on a COPD network meta-analysis were ruled misleading/unsubstantiated (Clauses 6.1, 6.2, 5.1). Allegations about MSLs acting…
Otsuka’s “Therapy Areas in Europe” webpage still referenced working with partner Akebia on CKD anaemia after the agreement ended. PMCPA ruled the…
PMCPA found Merck Serono failed to maintain high standards after two event co-chairs’ consultancy agreements were not agreed/signed in advance of services.…
Ex-employee alleged BI/Lilly alliance PMAP SOP and training were not accessible/controlled and that “agreements outside PMAP” existed. Panel found allegations not evidenced;…
PMCPA case AUTH/3870/1/24 against AstraZeneca concerned allegations about clinical trial material. The matter was found outwith the scope of the ABPI Code;…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.